A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the Hip

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00131326

Enrollment

Unknown

Registered

2005-08-18

Start date

2003-11-30

Completion date

2006-04-30

Last updated

2017-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases, Osteoarthritis, Hip

Keywords

osteoarthritis of the hip, Musculoskeletal Diseases

Brief summary

This is a clinical study to investigate the safety and efficacy of Synvisc and Depo-Medrol in treating patients with osteoarthritis (OA) of the hip.

Interventions

DEVICESynvisc (hylan G-F 20)

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

35 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with symptomatic osteoarthritis pain of hip

Exclusion criteria

* Patients with current or prior conditions or treatment that would impede measurement of efficacy and safety

Design outcomes

Primary

Measure	Time frame
Pain relief	—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026